Your browser doesn't support javascript.
loading
Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease.
Wu, Kai-Chun; Ran, Zhi Hua; Gao, Xiang; Chen, Minhu; Zhong, Jie; Sheng, Jian-Qiu; Kamm, Michael A; Travis, Simon; Wallace, Kori; Mostafa, Nael M; Shapiro, Marisa; Li, Yao; Thakkar, Roopal B; Robinson, Anne M.
Afiliação
  • Wu KC; Xijing Hospital of the Fourth Military Medical University, Xi'an, China.
  • Ran ZH; Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Gao X; The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Chen M; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Zhong J; Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Sheng JQ; The Military General Hospital of Beijing, PLA, Beijing, China.
  • Kamm MA; St. Vincent's Hospital and University of Melbourne, Melbourne, Australia.; Imperial College, London, UK.
  • Travis S; Translational Gastroenterology Unit, Oxford, UK.
  • Wallace K; AbbVie, North Chicago, Illinois, USA.
  • Mostafa NM; AbbVie, North Chicago, Illinois, USA.
  • Shapiro M; AbbVie, North Chicago, Illinois, USA.
  • Li Y; AbbVie, North Chicago, Illinois, USA.
  • Thakkar RB; AbbVie, North Chicago, Illinois, USA.
  • Robinson AM; AbbVie, North Chicago, Illinois, USA.
Intest Res ; 14(2): 152-63, 2016 Apr.
Article em En | MEDLINE | ID: mdl-27175116

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2016 Tipo de documento: Article